Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIRZEPATIDE vs TIVICAY: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TIRZEPATIDE vs TIVICAY: Safety Overview

Metric TIRZEPATIDE TIVICAY
Total FAERS Reports 99,893 128
Deaths Reported 455 0
Death Rate 0.5% N/A
Hospitalizations 5,527 22
Average Patient Age 53.9 yrs 46.4 yrs
% Female Patients 75.6% N/A
FDA Approval Date Jan 20, 2026 N/A
Manufacturer Eli Lilly and Company N/A
Marketing Status Prescription N/A